Tulinercept

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameTulinercept
Drug Alias NameTNFR-FcPRX-106OPRX-106
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionTumor necrosis factor inhibitors
TargetsTumor necrosis factor
Therapy Area/IndicationsColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesProtalix Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProtalix
Active IndicationsN/A
Inactive IndicationsColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A